TP53 and cancer: It was reported that an aberrant pyruvate metabolism plays an prominent role in cancer, and that cancer cells modulate pyruvate metabolism by the downregulation of p53 and by shifting the expression of glycolytic enzymes, such as pyruvate kinase [32].